Combination Treatment of Renal Cell Carcinoma with Belinostat and 5-Fluorouracil: A Role for Oxidative Stress Induced DNA Damage and HSP90 Regulated Thymidine Synthase-Reference-Cited by-同舟云学术

Combination Treatment of Renal Cell Carcinoma with Belinostat and 5-Fluorouracil: A Role for Oxidative Stress Induced DNA Damage and HSP90 Regulated Thymidine Synthase

Published:2015-05 Issue:5 Volume:193 Page:1660-1668
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kim Mi Joung¹,Lee Jee Suk¹,Park Sang Eun¹²,Yi Hye-Jin¹,Jeong In Gab¹³,Kang Jong Soon⁴,Yun Jieun⁴,Lee Joo-Yong²⁵,Ro Seonggu⁶,Lee Jung Shin¹⁷,Choi Eun Kyung¹⁸⁹,Hwang Jung Jin¹²⁵,Kim Choung-Soo¹³

Affiliation:

1. Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

2. Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

3. Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

4. Bio-Evaluation Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea

5. Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

6. CrystalGenomics, Inc., Gyeonggi-Do, Republic of Korea

7. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

8. Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

9. Center for Development and Commercialization of Anti-Cancer Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference29 articles.

1. Novel agents and approaches for advanced renal cell carcinoma;Figlin;J Urol,2012

2. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review;Gupta;Cancer Treat Rev,2008

3. Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial;Ravaud;Br J Cancer,2003

4. Systemic therapy in renal cell carcinoma: advancing paradigms;Posadas;Oncology (Williston Park),2012

5. Anticancer activities of histone deacetylase inhibitors;Bolden;Nat Rev Drug Discov,2006

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting apoptosis in clear cell renal cell carcinoma;Biomedicine & Pharmacotherapy;2024-06

2. Quisinostat is a brain-penetrant radiosensitizer in glioblastoma;JCI Insight;2023-11-22

3. Anticancer clinical efficiency and stochastic mechanisms of belinostat;Biomedicine & Pharmacotherapy;2023-09

4. Integrated analysis of the roles of oxidative stress related genes and prognostic value in clear cell renal cell carcinoma;Journal of Cancer Research and Clinical Oncology;2023-06-20

5. Integrated Analysis of the Roles of Oxidative stress related genes and Prognostic Value in Clear Cell Renal Cell Carcinoma;2023-04-26